BCTX
BriaCell Therapeutics Corp. (BCTX)
$56
About BriaCell Therapeutics Corp. (BCTX)
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
Details
Daily high
$0.62
Daily low
$0.56
Price at open
$0.62
52 Week High
$5.97
52 Week Low
$0.46
Market cap
24.8M
Dividend yield
0.00%
Volume
904,389
Avg. volume
2.4M
P/E ratio
-.63
BriaCell Therapeutics Corp. News
Details
Daily high
$0.62
Daily low
$0.56
Price at open
$0.62
52 Week High
$5.97
52 Week Low
$0.46
Market cap
24.8M
Dividend yield
0.00%
Volume
904,389
Avg. volume
2.4M
P/E ratio
-.63